Richard A. Zordani Jr., Director at GALECTIN THERAPEUTICS INC (GALT), bought 1,000 shares at $3.52 ($4K) on 2024-04-30, disclosed to the SEC on 2024-04-30.
Open-market purchase of $4k GALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| GALT | BUY | 2022-07-29 | $13K | — | Filing → |
| GALT | BUY | 2022-04-04 | $8K | — | Filing → |
| GALT | BUY | 2022-01-18 | $10K | — | Filing → |